
Helios Bioelectronics, Inc. is an innovative biotechnology company founded in 2016, dedicated to integrating semiconductor technology with biomarker detection. The company has developed advanced diagnostic tools through collaborations with industry leaders like TSMC and Episil Technologies, resulting in cutting-edge biochip systems. Their CMOS-based and nanowire FET systems enable high-throughput, multiplexed detection of biomarkers, making them suitable for applications in disease diagnosis, drug development, and environmental monitoring. With a focus on miniaturization and point-of-care testing, Helios aims to meet modern healthcare demands and expand its market presence through strategic partnerships.

Helios Bioelectronics, Inc. is an innovative biotechnology company founded in 2016, dedicated to integrating semiconductor technology with biomarker detection. The company has developed advanced diagnostic tools through collaborations with industry leaders like TSMC and Episil Technologies, resulting in cutting-edge biochip systems. Their CMOS-based and nanowire FET systems enable high-throughput, multiplexed detection of biomarkers, making them suitable for applications in disease diagnosis, drug development, and environmental monitoring. With a focus on miniaturization and point-of-care testing, Helios aims to meet modern healthcare demands and expand its market presence through strategic partnerships.